This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Induction of integration-free human-induced pluripotent stem cells under serum- and feeder-free conditions
In Vitro Cellular & Developmental Biology - Animal Open Access 25 November 2019
-
The effect of clinical-grade retinal pigment epithelium derived from human embryonic stem cells using different transplantation strategies
Protein & Cell Open Access 23 January 2019
-
Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials
Stem Cell Research & Therapy Open Access 08 November 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
10 October 2014
In the version of this article initially published, two author names were misspelled: the correct names are Cavagnaro, not Cavanagro; Feigal not Feigel. In addition, the name for the Health Insurance Portability and Accountability Act (HIPAA) was given as Health Insurance Portability and Privacy Act (HIPPA). The errors have been corrected in the HTML and PDF versions of the article.
References
Yamanaka, S. Cell Stem Cell 10, 678–684 (2012).
Rao, M.S. & Collins, F.S. Stem Cells Transl. Med. 1, 15–17 (2012).
Sipp, D. & Turner, L. Science 338, 1296–1297 (2012).
Allison, M. Nat. Biotechnol. 30, 304 (2012).
Ahrlund-Richter, L. et al. Cell Stem Cell 4, 20–26 (2009).
Carpenter, M.K. & Couture, L.A. Regen. Med. 5, 569–579 (2010).
Bravery, C.A. et al. Cytotherapy 15, 9–19 (2013).
Rawley, J. et al. BioProcess International 10, 16–22 (2012).
Clarke, D. Stanton J. Cytotherapy. 14, 1032–1040 (2012).
Lomax, G.P., Hull, S.C., Lowenthal, J., Rao, M. & Isasi, R. Stem Cells Transl. Med. 2, 727–730 (2013).
Lowenthal, J., Lipnick, S., Rao, M. & Hull, S.C. Stem Cells Trans. Med. 1, 409–421 (2012).
Magnus, D. J. Law Med. Ethics 38, 267–276 (2010).
Georgieva, B.P. & Love, J.M. Regen. Med. 5, 581–591 (2010).
Rao, M.S. Stem Cell Res. Ther. 4, 98 (2013).
Obasogie, O.K. & Theung, H. Stanford Technology Law Review 16, 51–78 (2012).
Turner, M. et al. Cell Stem Cell 13, 382–384 (2013).
http://www.fda.gov/internationalprograms/internationalcommunications/embassybriefings/ucm202888.htm
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Andrews, P., Cavagnaro, J., Deans, R. et al. Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells. Nat Biotechnol 32, 724–726 (2014). https://doi.org/10.1038/nbt.2973
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2973
This article is cited by
-
Establishment of a keratinocyte and fibroblast bank for clinical applications in Japan
Journal of Artificial Organs (2023)
-
Induction of integration-free human-induced pluripotent stem cells under serum- and feeder-free conditions
In Vitro Cellular & Developmental Biology - Animal (2020)
-
The effect of clinical-grade retinal pigment epithelium derived from human embryonic stem cells using different transplantation strategies
Protein & Cell (2019)
-
Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials
Stem Cell Research & Therapy (2018)
-
New strategies for improving stem cell therapy in ischemic heart disease
Heart Failure Reviews (2016)